南非私营部门药品定价是否透明？
Is there transparency in the pricing of medicines in the South African private sector?
作者信息
Bangalee V, Suleman F
机构信息
Discipline of Pharmaceutical Sciences, School of Health Sciences, Westville Campus, University of KwaZulu-Natal, Durban, South Africa.
出版信息
S Afr Med J. 2018 Feb 1;108(2):82-83. doi: 10.7196/SAMJ.2017.v108i2.12815.
Abstract
Recent investigations by the Competition Commission of South Africa (SA) of suspected excessive pricing of cancer medicines in SA by three global pharmaceutical companies have once again drawn attention to increasing medicine pricing transparency and warrant further public debate.
摘要
南非竞争委员会（SA）近期对三家全球制药公司在南非涉嫌癌症药物定价过高的调查，再次引发了对提高药品定价透明度的关注，并值得进一步展开公开辩论。
相似文献
1
Is there transparency in the pricing of medicines in the South African private sector?南非私营部门药品定价是否透明？
S Afr Med J. 2018 Feb 1;108(2):82-83. doi: 10.7196/SAMJ.2017.v108i2.12815.
2
Evaluating the impact of single exit pricing (SEP) on medicine product withdrawal from the private healthcare market in South Africa.评估单一退出定价（SEP）对南非药品退出私营医疗市场的影响。
S Afr Med J. 2021 Apr 30;111(5):444-447. doi: 10.7196/SAMJ.2021.v111i5.15297.
3
Evaluating the impact of the single exit price policy on a basket of originator medicines in South Africa from 1999 to 2014 using a time series analysis.利用时间序列分析评估南非 1999 年至 2014 年单一出口价格政策对一篮子原研药品的影响。
BMC Health Serv Res. 2019 Aug 16;19(1):576. doi: 10.1186/s12913-019-4403-8.
4
[Mechanism and implication of regulation of the pricing of essential medicines in the private pharmaceutical sector in Mali].[马里私营制药部门基本药物定价监管的机制与影响]
Med Trop (Mars). 2010 Apr;70(2):184-8.
5
Market spiral pricing of cancer drugs.癌症药物的市场螺旋式定价。
Cancer. 2013 Nov 15;119(22):3900-2. doi: 10.1002/cncr.28321. Epub 2013 Sep 3.
6
Medicines pricing singled out.药品定价被单独列出。
S Afr Med J. 2004 May;94(5):334.
7
Public- and private-sector partnerships in contraceptive research and development: guiding principles.
Int J Gynaecol Obstet. 1999 Dec;67 Suppl 2:S125-39. doi: 10.1016/s0020-7292(99)00156-3.
8
Pharmacoeconomics in the years of crisis: a solution or just a resolution? A Cyprus perspective.危机年代的药物经济学：是解决方案还是仅仅是一项决议？塞浦路斯视角。
Expert Rev Pharmacoecon Outcomes Res. 2014 Oct;14(5):627-36. doi: 10.1586/14737167.2014.917969. Epub 2014 Jun 23.
9
The impact of the single exit price policy on a basket of generic medicines in South Africa, using a time series analysis from 1999 to 2014.南非单一出口价格政策对一篮子仿制药的影响，采用 1999 年至 2014 年的时间序列分析。
PLoS One. 2019 Jul 31;14(7):e0219690. doi: 10.1371/journal.pone.0219690. eCollection 2019.
10
Understanding medicine access strategies for innovator medicines registered in South Africa.了解在南非注册的创新药物的药物获取策略。
BMC Health Serv Res. 2024 Oct 11;24(1):1220. doi: 10.1186/s12913-024-11696-4.
引用本文的文献
1
Consumers' Knowledge, Attitudes, and Practices Toward Medicine Price Transparency at Private Healthcare Setting in Malaysia.马来西亚私营医疗机构中消费者对药品价格透明度的知识、态度和行为。
Front Public Health. 2021 Aug 24;9:589734. doi: 10.3389/fpubh.2021.589734. eCollection 2021.
Zotero 插件